| Segment | Revenue | Share |
|---|---|---|
Other Products | $7.26B | 20.6% |
Prolia | $4.41B | 12.5% |
Repatha | $3.02B | 8.5% |
Otezla | $2.27B | 6.4% |
ENBREL | $2.23B | 6.3% |
EVENITY | $2.10B | 5.9% |
XGEVA | $2.08B | 5.9% |
TEPEZZA | $1.90B | 5.4% |
Product and Service, Other | $1.60B | 4.5% |
BLINCYTO | $1.56B | 4.4% |
Nplate | $1.52B | 4.3% |
TEZSPIRE | $1.48B | 4.2% |
Aranesp | $1.39B | 3.9% |
KRYSTEXXA | $1.34B | 3.8% |
Vectibix | $1.18B | 3.3% |
Other | $0 | 0.0% |
| Segment | Revenue | Share |
|---|---|---|
UNITED STATES | $26.42B | 71.9% |
Non-US | $10.33B | 28.1% |